Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Farmmi, Inc. is facing severe operational headwinds, characterized by a massive 56.38% year-over-year revenue decline to $27.97 million and a widening net loss of $53.10 million for the fiscal year ended September 30, 2025. The company's core agricultural business (edible fungi processing and sales) is shrinking rapidly, forcing it to pivot into highly competitive and unrelated sectors such as digital marketing and logistics. While these new subsidiaries (Bluesage and SuppChains Group) have achieved minor milestones, they have yet to demonstrate meaningful financial viability. Given the high volatility (Beta of 1.82), history of dilutive capital raises, and frequent reverse stock splits to maintain Nasdaq compliance, the stock carries substantial risk with limited near-term upside.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$0.5025%

The bear case is triggered by continued operational deterioration, failure of the new subsidiaries to generate meaningful cash flow, and further cash burn. This would likely lead to another breach of Nasdaq's minimum bid price rule, forcing further dilutive equity offerings or reverse stock splits, ultimately destroying shareholder value.

Base CaseCentral scenario
$1.1060%

The base case assumes that Farmmi's core agricultural revenue remains depressed or stabilizes at a low level, while its new digital marketing and logistics ventures contribute marginal revenues that fail to offset high operating expenses. The company will likely continue to operate at a net loss, requiring further dilutive capital raises to fund working capital, keeping the stock under pressure.

Bull CaseUpside scenario
$2.1015%

The bull case relies on a rapid and successful turnaround driven by its newly established digital marketing and logistics subsidiaries. If Bluesage secures high-value global contracts and SuppChains Group successfully scales its North American food supply chain operations, Farmmi could diversify its revenue streams and return to profitability, driving a significant re-rating of the stock.

Scenarios reflect our research view at the research date.

Key Investment Merits
  • Strategic pivot into high-growth sectors like digital marketing (Bluesage) and logistics (SuppChains Group).
  • Established international certifications (HACCP, BRC, QS) for its agricultural processing facilities, maintaining a baseline of product quality.
  • Active expansion in North American markets, including a new warehouse lease in New Jersey and FDA food facility registration.
Sign in / Sign up to read more
Key Investment Risks
  • Severe revenue contraction, with FY 2025 revenue declining by 56.38% year-over-year.
  • Substantial net losses, reaching $53.10 million in FY 2025 compared to a loss of $4.65 million in FY 2024.
  • High risk of equity dilution, as evidenced by frequent private placements and capital raises to fund operations.
  • History of reverse stock splits (such as the 1-to-12 split in March 2025) to maintain Nasdaq listing compliance.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Securing large-scale, highly profitable contracts by the digital marketing subsidiary (Bluesage) that materially reverse the company's net losses.
  2. A sudden, sustained recovery in the Chinese agricultural export market boosting core mushroom sales.
  3. Acquisition of the company or its key assets by a larger agricultural or logistics conglomerate at a premium.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.